PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.

Heartland Dental, Aspen Dental and PDS Health are the three largest DSOs and MSOs in the dental industry. Here is how the three organizations stack up based on the number of practices in their network ...

Foundation made significant progress in 2024, expanding access to essential oral health care and reaching more patients and communities than ever before. From expanding care for patients with special ...

Blue Trust Inc. increased its stake in shares of Precision Drilling Co. (NYSE:PDS – Free Report) (TSE:PD) by 64.7% in the ...

Robbinsville boys basketball advances past Princeton Day in the CVC Tournament with a clutch second half to set up a quarterfinal game at WW-P North ...

WCIA celebrates Black History Month and introduces viewers to influential people making a difference. One of those leaders is Larry Boone, Urbana's Police Chief.

In anticipation of the release of their highly awaited 22-track album, “No Song Hold On,” PDS has released another ...

Despite humanity's scientific achievements and globalized economy, malnutrition remains a global issue. The United Nations estimated that 2.33 billion people experienced moderate or severe food ...

WOOD RIVER Wood River Mayor Tom Stalcup and Police Chief Brad Wells presented the 2024 Officer of the Year award to Geoffrey ...